The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

Spurious drug manufacturers from other states are tarnishing the image of state’s pharmaceutical industry by using fictitious ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

OA affects about 15-20% of the Indian population, especially the elderly, with women being more vulnerable. It leads to joint ...

A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

The future of healthcare is not just new drugs; it is about smarter, more responsive solutions that prioritise patients ...

Further, India’s pharma industry is also more diversified compared to China’s, with a strong foothold in generics, biotech, and biosimilars. While we discussed the growth of the CDMO industry ...

Alembic Pharmaceuticals partners with Amlan International to bring innovative poultry health solutions to India's market.

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

A study linking Indian generic drugs to a higher risk of serious side effects in the US has spurred backlash from the Indian ...